MSD Innovation Factory is Looking for Digital Solutions for Anaesthesiologists

MSD is looking for innovators to solve 7 health-related challenges. One of them seeks to support anaesthesiologists with their continuous education (e.g. at the operation room) or their team building with surgeons. As a leading pharmaceutical company, MSD is aware of the need to incorporate innovation to deliver the best possible value to healthcare professionals, patients and customers. And that is the MSD Innovation Factory, where three out of the seven finalists (one per challenge) will get the top prize: up to $20,000 each to develop and locally launch the solution.

Co-create with a pharma and go together for unmet needs

MSD is having difficulty to reach anaesthesiologists to share the benefits of using Deep Block (DB) until the end of operations. Deep Block improves surgical conditions as it decreases the movement of the muscles and increases the volume at the operation area.

The main reason for not reaching them is their busy workload and the time spent at operation rooms, where MSD representatives cannot enter. There’s an opportunity for solutions oriented to education, e.g. while at the operating room, communication and team building with surgeons.

Worldwide participants are welcome to apply proposing solutions that will be implemented first in Turkey. The finalist of this challenge will have the opportunity to improve the proposal in collaboration with the local MSD team that proposed the challenge.

Find all the info about the anaesthesiologists challenge: https://www.msdinnovationfactory.com/challenges/anestouch/

Do you have a solution? Apply now!
www.msdinnovationfactory.com

How MSD Innovation Factory works

The innovation factory initiative aims to give support to the companies that come up with the best ideas to solve one of the 7 challenges identified in the EEMEA Region (Eastern Europe, Middle East and Africa) by local MSD teams.

The selection is done in four steps:

  • Solutions submitted before 31st October are reviewed by the challenge owners (the local MSD teams).
  • Each country will select the best solution for its proposed challenge.
  • During co-creation sessions the selected company and the local MSD team will work together in an improved proposal to be jointly presented in a Final event.
  • At the Final event in January 2018, the 7 finalists will pitch their solution in front of a senior jury from MSD. The jury will award 3 winners.

The prizes

Each of the 3 winners will receive the following:
  • Up to $20,000 to pilot their solution in the challenge-related local market.
  • Support from MSD local team to connect with the local ecosystem (eg. medical professional associations), deal with potential regulatory issues and disseminate leveraging MSD local channels. It will also contribute with expertise and business know-how.
  • If the local launch is a success after 12 months, its outcomes will be globally shared within MSD to investigate further implementation beyond the initial market.

All 7 finalists will get a 500€ grant to cover travel expenses to attend the Final event in Istanbul, and the opportunity to optimize their proposal in collaboration with the local MSD team that proposed the challenge. They will also receive visibility through the initiative communication channels.

MSD is a global healthcare company with a 125-year history committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.

Applications until 31 October

Do you have a solution? Apply now!
www.msdinnovationfactory.com

Most Popular Now

Brain-Computer Interface Enables People …

Tablets and other mobile computing devices are part of everyday life, but using them can be difficult for people with paralysis. New research from the BrainGate consortium shows that a...

AI System may Accelerate Search for Canc…

Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system. The system, called LION LBD and developed by computer scientists...

AI-Pathway Companion from Siemens Health…

At the Congress of the Radiological Society of North America (RSNA 2018) in Chicago, USA, Siemens Healthineers is presenting AI-Pathway Companion* for the first time. It is a clinical decision...

Philips Latest 'Future Health Index' Rep…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced publication of the latest Future Health Index (FHI) report. 'Telehealth: delivering value across institutional and geographical borders...

NHS Pioneers Win with InterSystems at HT…

Two pioneering NHS organisations have been recognised at the 2018 HTN Awards for their innovative work using InterSystems technology to help transform care for patients. The judges, who included GPs...

New China and US Studies Back Use of Pul…

Fast and easy blood pressure monitoring could soon be at your fingertips - literally - thanks to new University of British Columbia research that showed blood pressure (BP) can be...

AOK Counts on the Orchestra eHealth Suit…

The AOK community builds a digital health network for its insurants and thus takes on a pioneering task among German health insurances. Through the digital health network its 25 million...

Australian Health Region Boosts Patient …

Patients and clinicians will benefit from easy access to critical real-time patient information at the bedside after Australian population health services provider ACT Health signed a further contract with Patientrack's...

Syntropy to Unlock the Value of Scientif…

Merck, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to...

FDA Grants Breakthrough Device Designati…

Bayer announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition, which Bayer is...

DIATOMIC Launches its Final Call to Dist…

In its second and final open call for application experiments, DIATOMIC is offering a total of €1.610.000 equity-free funding plus acceleration services to the best startups/ SMEs and Competence Centers...